Quick Answer
InspireMD, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $8.98 million for the year ending 2025.
- InspireMD, Inc. showed an increase of +28.1% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from InspireMD, Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2017: $640.0 thousand | Q3 2017: $718.0 thousand | Q1 2018: $1.01 million | Q2 2018: $1.00 million | Q3 2018: $769.0 thousand | Q1 2019: $415.0 thousand | Q2 2019: $1.35 million | Q3 2019: $939.0 thousand | Q1 2020: $1.03 million | Q2 2020: $313.0 thousand | Q3 2020: $980.0 thousand | Q1 2021: $1.01 million | Q2 2021: $1.04 million | Q3 2021: $1.07 million | Q1 2022: $1.18 million | Q2 2022: $1.53 million | Q3 2022: $1.43 million | Q1 2023: $1.24 million | Q2 2023: $1.65 million | Q3 2023: $1.56 million | Q1 2024: $1.51 million | Q2 2024: $1.74 million | Q3 2024: $1.81 million | Q1 2025: $1.53 million | Q2 2025: $1.78 million | Q3 2025: $2.52 million.
- Over the full 9 years of available data (2017 to 2025), InspireMD, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 225.2%.
- Historical annual values: Fiscal year 2025: $8.98 million | Fiscal year 2024: $7.01 million | Fiscal year 2023: $6.21 million | Fiscal year 2022: $5.17 million | Fiscal year 2021: $4.50 million | Fiscal year 2020: $2.49 million | Fiscal year 2019: $3.72 million | Fiscal year 2018: $3.60 million | Fiscal year 2017: $2.76 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: